Higher Cytokine Levels in Tumor-Infiltrating Lymphocytes of Kidney Cancer Patients
Author Information
Author(s): Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U
Primary Institution: Department of Urology, University of Freiburg
Hypothesis
The study investigates the expression levels of cytokines in tumor-infiltrating lymphocytes compared to peripheral blood lymphocytes in renal cell carcinoma patients.
Conclusion
Tumor-infiltrating lymphocytes in kidney cancer patients show significantly higher levels of certain cytokines compared to peripheral blood lymphocytes.
Supporting Evidence
- CD4+ tumor-infiltrating lymphocytes had significantly higher mRNA levels of IFN-γ, IL-10, and FasL compared to peripheral blood lymphocytes.
- CD8+ tumor-infiltrating lymphocytes also showed higher expression of IFN-γ, IL-10, and FasL compared to peripheral blood lymphocytes.
- TNF-α mRNA levels were lower in CD8+ tumor-infiltrating lymphocytes than in peripheral blood lymphocytes.
Takeaway
Doctors looked at special immune cells in kidney cancer patients and found that the ones in the tumors had more signals that help fight the cancer than those in the blood.
Methodology
The study compared mRNA expression of cytokines in tumor-infiltrating lymphocytes and peripheral blood lymphocytes using PCR-assisted mRNA amplification.
Participant Demographics
Patients with renal cell carcinoma.
Statistical Information
P-Value
P≤ 0.001, P≤ 0.05, P≤ 0.01
Statistical Significance
p≤0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website